The schizophrenic career of a "monster drug".
Crawford
C L
CL
D003622:Dapsone / Q000627:therapeutic use; D004893:Erythema Nodosum / Q000188:drug therapy*; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use; D007918:Leprosy / Q000517:prevention & control; D015440:Leprosy, Lepromatous / Q000188:drug therapy*; D009422:Nervous System Diseases / Q000139:chemically induced*; D017511:Pyoderma Gangrenosum / Q000188:drug therapy; D013792:Thalidomide / Q000009:adverse effects* / Q000627:therapeutic use
D007917:Leprostatic Agents; D013792:Thalidomide; D003622:Dapsone